By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZIOPHARM Oncology, Inc. 

1180 Avenue of the Americas
19th Floor
New York  New York  10036  U.S.A.
Phone: 646-214-0700 Fax: 646-214-0711


Company News
ZIOPHARM Oncology (ZIOP.OB) Announces Data Highlighting Ad-RTS-Hil-12 Activity In Glioma At SNO 11/19/2015 7:57:36 AM
ZIOPHARM Oncology (ZIOP.OB) Reports Third-Quarter 2015 Financial Results And Recent Activities 11/3/2015 10:17:10 AM
Intrexon And ZIOPHARM Oncology (ZIOP.OB) To Develop Immunotherapies For Treatment Of Graft-Versus-Host Disease 9/29/2015 6:54:56 AM
ZIOPHARM Oncology (ZIOP.OB) Announces Presentation Of Clinical And Preclinical Data From Ad-RTS-IL-12 At CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference 9/21/2015 8:02:42 AM
ZIOPHARM Oncology (ZIOP.OB) To Present At The Wells Fargo 10th Annual Health Care Conference 9/3/2015 10:33:15 AM
ZIOPHARM Oncology (ZIOP.OB) Announces Cancer Research Publication Of Study Demonstrating Preferential Targeting Of Solid Tumor Cells By Modified CAR T Cells 9/1/2015 8:41:06 AM
ZIOPHARM Oncology (ZIOP.OB) Reports Second-Quarter 2015 Financial Results And Recent Activities 8/11/2015 1:21:16 PM
ZIOPHARM Oncology (ZIOP.OB) Announces Orphan Drug Designation For Ad-RTS-Hil-12 In The Treatment Of Malignant Glioma 7/27/2015 7:20:11 AM
Why Some Investors Think 27-Employee ZIOPHARM Oncology (ZIOP.OB) is Destined for a $10 Billion Merger 6/12/2015 6:09:08 AM
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer 6/2/2015 8:22:48 AM